Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia

Adamantia Liapikou, Catia Cillóniz, Albert Gabarrús, Rosanel Amaro, Jorge Puig De la Bellacasa, Josep Mensa, Marcelo Sánchez, Michael Niederman, Antoni Torres
European Respiratory Journal 2016 48: 257-261; DOI: 10.1183/13993003.00191-2016
Adamantia Liapikou
16th Respiratory Dept, Sotiria Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catia Cillóniz
2Dept of Pneumology, Institut Clinic del Tórax, Hospital Clínic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911 - Ciber de Enfermedades Respiratorias (Ciberes) Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Gabarrús
2Dept of Pneumology, Institut Clinic del Tórax, Hospital Clínic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911 - Ciber de Enfermedades Respiratorias (Ciberes) Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosanel Amaro
2Dept of Pneumology, Institut Clinic del Tórax, Hospital Clínic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911 - Ciber de Enfermedades Respiratorias (Ciberes) Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Puig De la Bellacasa
3Microbiology Dept, Hospital Clínic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josep Mensa
4Infectious Diseases Dept, Hospital Clínic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Sánchez
5Radiology Department, Hospital Clínic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Niederman
6Pulmonary and Critical Care Division, Weill Cornell Medical College, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoni Torres
2Dept of Pneumology, Institut Clinic del Tórax, Hospital Clínic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911 - Ciber de Enfermedades Respiratorias (Ciberes) Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: atorres@clinic.ub.es
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Bilateral but not unilateral multilobar pneumonia is an independent risk factor for mortality in CAP http://ow.ly/ZNLD4

To the Editor:

Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality worldwide [1]. Studies from the USA and Europe suggest that severe CAP patients requiring admission to the intensive care unit (ICU) reach a mortality of up to 39% [2, 3].

Since potential poor prognosis is known to contribute to increased ICU admissions, anticipating complications through the use of supporting measurements becomes essential. The 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) guidelines [1] have redefined severe CAP and indications for ICU admission, with a rule consisting of major and minor clinical criteria. The rule is considered positive if one major or three minor criteria are present [1]. The presence of multilobar infiltrates is included among the minor criteria. However, multilobar pneumonia can be bilateral or unilateral and this difference may be of some importance. Our hypothesis was that radiographical bilateral pneumonia is an independent risk factor for mortality and that the prognosis for bilateral involvement is worse than that for multilobar unilateral involvement. We, therefore, studied the clinical characteristics and outcomes of bilateral pneumonia (at admission) compared to unilateral multilobar and localised pneumonia.

We performed a prospective observational study at Hospital Clínic, Barcelona, Spain. The study population consisted of adults with a diagnosis of CAP, consecutively examined from 2000 to 2013. In the initial visit, patients underwent a complete history and physical examination and laboratory testing. Patients were stratified into risk classes using the pneumonia severity index [4] and the CURB-65 scores (CURB-65: confusion, urea >7 mmol·L−1, respiratory rate ≥30 breaths·min−1, blood pressure 90 mmHg (systolic) ≤60 mmHg (diastolic), age ≥65 years) [5]. All surviving patients were seen between 30 and 40 days after discharge. Multilobar pneumonia was defined as chest-radiograph infiltrates involving ≥2 lobes; bilateral when the involved lobes were in both the right and left lungs, unilateral when the affected involved lobes were in the same lung, and localised when only a single pulmonary lobe was involved. Patients were categorised into three groups according to the presence of infiltrates: bilateral, multilobar unilateral and localised pneumonia. All CAP patients had lateral and anteroposterior (PA) projections to categorise radiographic involvement. All chest radiographs were reviewed by one specialist in lung radiology (M. Sánchez) to evaluate the radiographical pattern of infiltrate, number of lobes involved, and the presence of pleural effusion and atelectasis; the specialist was blinded to the clinical data.

Of the 5084 CAP patients screened, 4644 were included in this study. Of these, 1069 (23%) had multilobar pneumonia and 585 (13%) presented bilateral infiltrates; unilateral infiltrates were present in 484 (45%) patients. Localised infiltrates were present in 3575 patients (77%).

Patients from the bilateral group were younger, more frequently former alcohol consumers, had more often received previous antibiotic treatment, but less frequently influenza vaccine and inhaled corticosteroids, presented less frequently with chronic respiratory disease, chronic cardiovascular disease, or diabetes mellitus as a comorbidity, and pleuritic pain at admission. Patients from the unilateral multilobar group had a higher rate of chronic liver disease at admission. According to arterial oxygen tension (PaO2) inspiratory oxygen fraction FIO2 ratio (PaO2/FIO2) and the presence of infiltrates on the chest radiograph, we found significant differences between localised group versus unilateral multilobar group median (interquartile range) of 267 (226–314) versus 292 (252–335), p=0.001 and between localised versus multilobar bilateral of 292 (252–335) versus 257 (219–300), p=0.001. Interestingly we did not find differences between multilobar bilateral versus unilateral multilobar was 257 (219–300) versus 267 (226–314), p=0.28.

Confirmed aetiology was found in 1821 (39%) patients. The most frequent pathogens were Streptococcus pneumoniae (n=768, 42%). Pathogens did not differ between groups, except for S. pneumoniae, which was less frequent in bilateral patients (bilateral 34%, unilateral multilobar 44%, and localised 43%; p=0.013), and Staphylococcus aureus was more frequent in the unilateral multilobar group (bilateral 3%, unilateral multilobar 5% and localised 2%; p=0.025).

Of the 585 patients with bilateral involvement, 198 (34%) were admitted to the ICU; 81 (16%) patients required invasive mechanical ventilation more frequently than the unilateral multilobar (n=39, 10%) and localised groups (n=97, 3%), (p<0.001). Patients with bilateral involvement had a longer stay in hospital than the localised group (bilateral 8 days; unilateral multilobar 9 days and localised 6 days; p<0.001). A total of 260 (6%) patients died and a 30-day mortality was significantly higher among bilateral patients (bilateral 11%, unilateral multilobar 7% and localised 4%; p<0.001).

In the multivariate analysis, age (≥65 years), neurological disease, chronic liver disease, altered mental status, PaO2/FIO2 <250, acute renal failure, septic shock, interstitial pattern, and bilateral involvement were risk factors for 30-day mortality. Unilateral multilobar involvement was not an independent factor associated with 30-day mortality (table 1). The area under the receiver operating characteristic (ROC) curve of the predictive model was 0.88 (95% CI 0.85–0.90).

View this table:
  • View inline
  • View popup
TABLE 1

Significant univariate and multivariate logistic regression analyses of predictors for 30-day mortality

In a large population of CAP patients, we showed that 23% of patients with CAP had multilobar infiltrates and 13% showed bilateral multilobar involvement on the chest radiograph. Our main findings are: 1) the clinical course of the bilateral group was severe, with more patients requiring admission to the ICU and mechanical ventilation compared to patients with unilateral multilobar and localised disease; and 2) more importantly, the presence of bilateral involvement was an independent predictive factor for mortality, while unilateral multilobar disease was not.

The association of multilobar involvement with prognosis has been previously investigated in some studies [6–8], as it is one of the IDSA/ATS minor criteria for ICU admission in CAP [1]. Many studies have evaluated these criteria, especially the minor criteria [6, 7, 9–12], with conflicting results. In the study by Chalmers et al. [10], the predictive value of multilobar shadowing was strong, with an OR of 4.20 (95% CI 2.56–6.88) for mechanical ventilation/vasopressor support (MV/VS) and an OR of 5.63 (95% Cl 3.09–10.3) for 30-day mortality.

Aliberti et al. [13] in a multicentre observational study of CAP cases observed the highest in-hospital mortality among CAP patients with acute respiratory failure, severe sepsis and multilobar infiltrates (26%).

Rello et al. [14], in a study evaluating 428 ICU patients with CAP, including 126 chronic obstructive pulmonary disease (COPD) patients, reported that ICU mortality in COPD patients with adequate therapy was associated with bilateral infiltrates and shock. In fact, their study and that of Walden et al. [15], which included patients with severe CAP, looked at bilateral involvement as a predictor of mortality.

Similarly, the meta-analysis by Mannu et al. [16] has shown multilobar involvement to be associated with unfavourable outcomes, such as a significantly increased risk of mortality (OR 2.57, 95% CI 1.83–3.61) in all seven studies analysed. Bilateral involvement was not analysed separately.

We also examined the mortality factors in the group of patients with bilateral and unilateral multilobar pneumonia and found that bilateral, but not unilateral involvement was an independent predictive factor for 30-day mortality in CAP patients.

The strengths of this study are the large number of patients enrolled over a long period of time, its prospective design, and the comprehensive clinical and microbiological data gathered. Limitations include the fact that it is a single-centre study, therefore the results need to be validated in external cohorts, and the lack of computed tomography (CT) scan data to compare chest radiographs with. Recently, Claessens et al.[17] highlighted specificity and sensitivity problems of chest radiographs compared to CT scans in CAP. However, performing CT scans for CAP is unfeasible in routine clinical practice.

In summary, bilateral chest radiographs involvement was an independent factor associated with higher mortality, whereas unilateral multilobar pneumonia was not. We suggest including bilateral instead of multilobar pneumonia in the scores for prognosis and ICU admission in CAP.

Acknowledgements

We are indebted to all medical and nursing colleagues for their assistance and cooperation in this study.

Footnotes

  • Support statement: This work was supported by Ciber de Enfermedades Respiratorias (CibeRes CB06/06/0028). 2009 Support to Research Groups of Catalonia 911.

  • Conflict of interest: None declared.

  • Received January 26, 2016.
  • Accepted March 8, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Mandell LA,
    2. Wunderink RG,
    3. Anzueto A, et al.
    Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27–S72.
    OpenUrl
  2. ↵
    1. Lim WS,
    2. Baudouin SV,
    3. George RC, et al.
    BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–iii55.
    OpenUrl
  3. ↵
    1. Garcia-Vidal C,
    2. Fernández-Sabe N,
    3. Carratala J, et al.
    Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 2008; 32: 733–739.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Fine MJ,
    2. Auble TE,
    3. Yealy DM, et al.
    A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243–250.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Lim WS,
    2. van der Eerden MM,
    3. Laing R, et al.
    Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377–382.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Liapikou A,
    2. Ferrer M,
    3. Polverino E, et al.
    Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to predict an intensive care unit admission. Clin Infect Dis 2009; 48: 377–385.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Chalmers JD,
    2. Taylor JK,
    3. Mandal P, et al.
    Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 2011; 53: 503–511.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Lim HF,
    2. Phua J,
    3. Mukhopadhyay A, et al.
    IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia. Eur Respir J 2014; 43: 852–862.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Viasus D,
    2. Garcia-Vidal C,
    3. Manresa F, et al.
    Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect 2013; 66: 27–33.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Chalmers JD
    . ICU admission and severity assessment in community-acquired pneumonia. Crit Care 2009; 13: 156.
    OpenUrlCrossRefPubMed
    1. Phua J,
    2. See KC,
    3. Chan YH, et al.
    Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 2009; 64: 598–603.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Singanayagam A,
    2. Chalmers JD,
    3. Hill AT
    . Severity assessment in community-acquired pneumonia: a review. QJM 2009; 102: 379–388.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Aliberti S,
    2. Brambilla AM,
    3. Chalmers JD, et al.
    Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res 2014; 15: 27.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Rello J,
    2. Rodriguez A,
    3. Torres A, et al.
    Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006; 27: 1210–1216.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Walden AP,
    2. Clarke GM,
    3. McKechnie S, et al.
    Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Crit Care 2014; 18: R58.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Mannu GS,
    2. Loke YK,
    3. Curtain JP, et al.
    Prognosis of multi-lobar pneumonia in community-acquired pneumonia: a systematic review and meta-analysis. Eur J Intern Med 2013; 24: 857–863.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Claessens YE,
    2. Debray MP,
    3. Tubach F, et al.
    Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med 2015; 192: 974–982.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
View this article with LENS
Vol 48 Issue 1 Table of Contents
European Respiratory Journal: 48 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia
Adamantia Liapikou, Catia Cillóniz, Albert Gabarrús, Rosanel Amaro, Jorge Puig De la Bellacasa, Josep Mensa, Marcelo Sánchez, Michael Niederman, Antoni Torres
European Respiratory Journal Jul 2016, 48 (1) 257-261; DOI: 10.1183/13993003.00191-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia
Adamantia Liapikou, Catia Cillóniz, Albert Gabarrús, Rosanel Amaro, Jorge Puig De la Bellacasa, Josep Mensa, Marcelo Sánchez, Michael Niederman, Antoni Torres
European Respiratory Journal Jul 2016, 48 (1) 257-261; DOI: 10.1183/13993003.00191-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Research letters

  • Impact of depression and anxiety on exacerbation risk in bronchiectasis
  • Respiratory management of drowning-associated ARF
  • Mitochondrial DNA as biomarker of survival in RA-ILD
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society